Business analyst - portfolio and capacity management jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 4 hours ago

Business analyst - portfolio and capacity management

Alexion Pharmaceuticals, Inc. is dedicated to meeting patients' unmet needs worldwide. The Business Analyst will connect data-driven insights to strategic decisions across oncology and biopharma therapy areas, focusing on resource allocation and clinical planning to enhance portfolio direction and operational processes.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Capacity and Demand Analysis: Perform analyses within and across therapy areas. (Oncology and BioPharma) to generate insights that refine demand algorithms, balance capacity, and optimize clinical planning
Portfolio Analysis and Tracking: Build a detailed understanding of the BioPharma Clinical Operations portfolio by partnering with Portfolio & Capacity Management TA Leads, analyzing past and present data, and anticipating future changes
Portfolio Modelling: Provide effective modelling capability and high quality ad hoc analysis to Functional Leadership Teams and other stakeholders; represent BioPharma Clinical Operations and provide clinical input to AZ R&D modelling to inform decisions
Portfolio Review Support: Develop options to address resource constraints and support resource implications at the Capacity Management Team, ensuring trade-offs are transparent and actionable
Data Quality Leadership: Take the technical lead to ensure data quality in source systems (PLANIT, CAPIT, etc.) and maintain visibility of data across BioPharma Clinical Operations; work closely with Clinical Planning support (PLANIT Experts) and TA Leads to report and resolve issues promptly
Operational Processes: Develop and maintain processes and technologies that underpin key operational business activities and support new business strategies as they emerge
End-to-End Clinical Planning: Support the Director, Aggregate Planning within the Portfolio & Capacity team in line with ongoing Clinical Study Planning initiatives, connecting near-term needs to long-term portfolio health
Business Initiatives and Benchmarking: Engage in improvement projects such as reorganisation or redesign, and contribute to benchmarking activities that inform best practice and future capability

Qualification

Data analysisPortfolio managementPharmaceutical industry experienceExcelSQLETLPythonPower BIData architectureStakeholder managementMulti-cultural teamworkCommunication skills

Required

Minimum of university degree in the field of business or science
Minimum of 5 years of related experience with strong analytical background
Great technical skills and experience (excel, SQL, ETL, Python, power BI, SMART Sheet, Airtable etc)
Exposure to or experience of Portfolio analysis and management, either professionally or academically
Experience working in the pharma industry
Thorough knowledge of the pharmaceutical drug development process
Experience in modelling and databases, and data architecture

Preferred

Experience of effective working in a multi-cultural team
Proven stakeholder management
Flexibility to react to different customer needs for data/information
Experience of communicating complex information at a senior level (verbally and written)

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

H1B Sponsorship

Alexion Pharmaceuticals, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (49)
2024 (57)
2023 (51)
2022 (29)
2021 (27)
2020 (17)

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase